Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Eric Weisblum is Chief Executive Officer at Silo Pharma. OQRO lists 10 transactions filed with the SEC under this name, the latest on Dec 16, 2025, each linked to the official Form 4.
Chief Executive Officer
Disclosures on record
10
Companies involved
1
6 buys, median +3.6 pts vs S&P 500, beat it 3 of 6 times.
Average +7.0 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Nov 22, 2024 to Dec 16, 2025, measured from the first close after the filing. Past results, not a forecast.
6 purchases disclosed; 50% of the 6 measured at 90 days finished ahead of the index. $1,000 placed after each of the 3 purchases disclosed since 2025-11-16 would be worth $908 today ($3K put in); the same in the S&P 500 (SPY): $3.4K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Equal weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Silo PharmaSILO
10 disclosures · Nov 2024 – Dec 2025 · 10 bought
Dec 15, 2025Bought~$1.1Kdisclosed Dec 16
DetailsOfficial recordDec 15, 2025Bought~$1Kdisclosed Dec 16
DetailsOfficial recordNov 20, 2025Bought~$370disclosed Nov 21
DetailsOfficial recordNov 21, 2025Bought~$365
DetailsOfficial recordNov 18, 2025Bought~$3Kdisclosed Nov 20
DetailsOfficial recordNov 19, 2025Bought~$1.8Kdisclosed Nov 20
DetailsOfficial recordMay 27, 2025Bought~$4.3Kdisclosed May 28
DetailsOfficial recordDec 13, 2024Bought~$2.1Kdisclosed Dec 16
DetailsOfficial recordNov 20, 2024Bought~$2.4Kdisclosed Nov 22
DetailsOfficial recordNov 22, 2024Bought~$2.3K
DetailsOfficial recordAs of the latest filing on , Eric Weisblum reported holding 216,932 shares of Silo Pharma (SILO), worth about $342K at the last close of $2 (Nov 16, 2026). In the last 12 months, Eric Weisblum bought $7.7K in 6 open-market purchases.
Silo Pharma's proxy statement reports total compensation of $522K for Eric Weisblum for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received. Proxy statement filed Jun 30, 2026
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Silo Pharma SILO | 216,932 | 217K direct | $2 | $342K | Dec 15, 2025 |
Is this Eric Weisblum’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Eric Weisblum bought shares on the open market in 2019, 2021, 2022, 2023, 2024 and 2025.
Eric Weisblum reported 43 open-market purchases and 0 sales since 2019; purchases in 6 different years, most recently 2025.
| Year | Bought | Sold |
|---|---|---|
| 2025 | $12K7×7 trades | — |
| 2024 | $23K9×9 trades | — |
| 2023 | $26K17×17 trades | — |
| 2022 | $4.7K5×5 trades | — |
| 2021 | $3.3K2×2 trades | — |
| 2019 | $1663×3 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Dec 15, 2025, Eric Weisblum reported holding 216,932 shares of Silo Pharma (SILO). At the last close of $2 on Nov 16, 2026, that is about $342K. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, Eric Weisblum reported 6 open-market purchases worth $7.7K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Silo Pharma's proxy statement reports total compensation of $522K for Eric Weisblum for fiscal year 2025. The total is the one in the Summary Compensation Table: it counts stock awards at their value on the grant date, so it is not the cash received.
Eric Weisblum bought shares on the open market in 2019, 2021, 2022, 2023, 2024 and 2025.
In SEC filings since 2019: the latest open-market purchase is from 2025; no open-market sale is on record.
Silo Pharma (SILO), from 2019 to 2025: 43 purchases and 0 sales.
Eric Weisblum reported 43 open-market purchases and 0 sales here, 2019 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.